A multi-strain probiotic formulation alleviates chronic constipation in middle-aged and older adults: A randomized, double-blind, placebo-controlled trial
Clinical Nutrition · 2026
DOI: 10.1016/j.clnu.2026.106598 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Nutrition, 2026. Verfasst von Rui Xiao und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, Jiangsu, PR China; School of Food Science and Technology, Jiang…. Hauptthemen laut MEDLINE: Probiotics, Constipation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Collaborative Innovationcenter of Food Safety and Quality Control in Jiangsu Province, National Natural Science Foundation of China.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
BACKGROUND & AIMS: Chronic constipation is prevalent among middle-aged and older adults, with current interventions often limited by modest efficacy and adverse effects. Probiotics have emerged as a safe, promising modality; we aimed to evaluate a 28-day multi-strain probiotic in this population using clinical and mechanistic endpoints. METHODS: We conducted a randomized, double-blind, placebo-controlled trial in adults with chronic constipation: 132 were randomized (probiotics n = 66; placebo n = 66), and 100 completed per protocol (50/50).The primary endpoint was weekly complete spontaneous bowel movements (CSBMs) at day 28; secondary endpoints included Bristol Stool Form Scale (BSFS), Patient Assessment of Constipation Symptoms (PAC-SYM), bloating scores, and multi-omics profiling (gut microbiota and fecal metabolites at days 0/14/28), with targeted fecal short-chain fatty acids (SCFAs). A pre-specified responder was defined as week-4 CSBMs ≥3 and increases ≥1 from baseline. RESULTS: At day 28, probiotics yielded higher CSBMs than placebo (4.53 ± 1.17 vs 2.40 ± 1.01, P 0.05). Responder rates were 88 % (44/50) with probiotics versus 26 % (13/50) with placebo; within the probiotic arm, ΔFaecalibacterium and Δbutyrate correlated positively with ΔCSBM, while ΔEnterobacter correlated negatively. CONCLUSIONS: In middle-aged and older adults with chronic constipation, a 28-day multi-strain probiotic significantly increases bowel movement frequency, improves symptoms-especially bloating-and favorably remodels gut microbiota and SCFA-related pathways, supporting its use as a nutritional intervention. TRIAL REGISTRATION: ChiCTR2200065905.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, Jiangsu, PR China; School of Food Science and Technology, Jiangnan University, Wuxi 214122, Jiangsu, PR China.
- Department of Ultrasound, The Affiliated Yixing Hospital of Jiangsu University, Wuxi 214200, Jiangsu, PR China.
- State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, Jiangsu, PR China; Department of Clinical Laboratory, The Affiliated Yixing Hospital of Jiangsu University, Wuxi 214200, Jiangsu, PR…
- State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, Jiangsu, PR China; School of Food Science and Technology, Jiangnan University, Wuxi 214122, Jiangsu, PR China; National Engineering R…
- Department of Ultrasound, The Affiliated Yixing Hospital of Jiangsu University, Wuxi 214200, Jiangsu, PR China. Electronic address: JianfengGuo752@163.com.
Förderung
- Fundamental Research Funds for the Central Universities
- Collaborative Innovationcenter of Food Safety and Quality Control in Jiangsu Province
- National Natural Science Foundation of China
- Graduate Research and Innovation Projects of Jiangsu Province
Zitieren
APA
Xiao, R., He, Y., Mao, X., Sun, L., Ao, L., Wang, L., Zhai, Q., Zhao, J., Chen, W., Wang, G., & Guo, J. (2026). A multi-strain probiotic formulation alleviates chronic constipation in middle-aged and older adults: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2026.106598
Vancouver
Xiao R, He Y, Mao X, Sun L, Ao L, Wang L, et al. A multi-strain probiotic formulation alleviates chronic constipation in middle-aged and older adults: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition. 2026. doi:10.1016/j.clnu.2026.106598
BibTeX
@article{Xiao2026,
author = {Xiao, Rui and He, Yeping and Mao, Xuhua and Sun, Lei and Ao, Lanxi and Wang, Linlin and Zhai, Qixiao and Zhao, Jianxin and Chen, Wei and Wang, Gang and Guo, Jianfeng},
title = {A multi-strain probiotic formulation alleviates chronic constipation in middle-aged and older adults: A randomized, double-blind, placebo-controlled trial},
journal = {Clinical Nutrition},
year = {2026},
doi = {10.1016/j.clnu.2026.106598}
}
EUVIMED